Novartis AG (LON:0QLR)
104.50
-0.23 (-0.22%)
At close: Nov 28, 2025
Novartis AG Revenue
Novartis AG had revenue of $14.36B USD in the quarter ending September 30, 2025, with 4,014.04% growth. This brings the company's revenue in the last twelve months to $2.02B, up 49.52% year-over-year. In the year 2024, Novartis AG had annual revenue of $1.41B with 15.16% growth.
Revenue (ttm)
$2.02B
Revenue Growth
+49.52%
P/S Ratio
4.49
Revenue / Employee
$26.66K
Employees
75,883
Market Cap
188.41B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.41B | 185.00M | 15.16% |
| Dec 31, 2023 | 1.22B | -35.00M | -2.79% |
| Dec 31, 2022 | 1.26B | 62.00M | 5.20% |
| Dec 31, 2021 | 1.19B | -48.71B | -97.61% |
| Dec 31, 2020 | 49.90B | 1.27B | 2.62% |
| Dec 31, 2019 | 48.62B | 2.61B | 5.67% |
| Dec 31, 2018 | 46.02B | 2.66B | 6.13% |
| Dec 31, 2017 | 43.36B | -6.08B | -12.29% |
| Dec 31, 2016 | 49.44B | -925.00M | -1.84% |
| Dec 31, 2015 | 50.36B | -1.82B | -3.49% |
| Dec 31, 2014 | 52.18B | 311.00M | 0.60% |
| Dec 31, 2013 | 51.87B | 789.00M | 1.54% |
| Dec 31, 2012 | 51.08B | -8.30B | -13.97% |
| Dec 31, 2011 | 59.38B | 7.81B | 15.15% |
| Dec 31, 2010 | 51.56B | 6.46B | 14.32% |
| Dec 31, 2009 | 45.10B | 2.52B | 5.92% |
| Dec 31, 2008 | 42.58B | 41.71B | 4,766.74% |
| Dec 31, 2007 | 875.00M | 163.00M | 22.89% |
| Dec 31, 2006 | 712.00M | 405.00M | 131.92% |
| Dec 31, 2005 | 307.00M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |